Summary of Action

In 1999, the Federal Trade Commission entered an order against Jason P. Boreyko, his brother Benson K. Boreyko, and companies New Vision International, Inc. and NVI Promotions, L.L.C., that prohibits them (directly or through any corporation) from claiming that any dietary supplement, drug, or food can treat, cure, alleviate the symptoms of, prevent, or reduce the risk of developing any disease or disorder without having competent and reliable scientific evidence to substantiate the claim. investigated Jason Boreyko and his California-based multi-level marketing company SevenPoint2 and found evidence that Mr. Boreyko is violating the 1999 FTC Order. Specifically, SevenPoint2 makes — both directly, as well as through its distributors — numerous health and disease-treatment claims about its products.  And, upon information and belief, the company does not have any competent and reliable scientific evidence to substantiate these claims, as required by law, as well as the 1999 FTC Order.

As a result, sent a letter on April 26, 2016 to the FTC notifying it of the violation.  More than a year later, SevenPoint2 informed that it had “successfully requested the removal and/or modification of the unsubstantiated disease and health claims” at issue.

Of note, previously investigated Jason Boreyko’s brother, Benson K. Boreyko, and his company, Vemma Nutrition Company, and found, among other things, that they have violated this very same 1999 FTC Order. For more information on’s investigation of Vemma, click here.

Print Friendly, PDF & Email


Leave a Reply

Back to Top ↑